Právní předpis byl sestaven k datu 22.02.2023.
Zobrazené znění právního předpisu je účinné od 22.02.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2023
41/2023 Sb.
41
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx xxx 10. xxxxx 2023
x xxxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2023
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. x) zákona x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx některých souvisejících xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx základě doporučení Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx pro xxx 2023:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 dávka (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 ne méně xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani xxxxxxxxxx1 xx xxxx xxx 40 mezinárodních jednotek (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)1 25 xxxxxxxxxx Xxxxxxxxxxx (PRN)1 8 xxxxxxxxxx
Xxxxxxxxx tegiminis hepatitidis X (HBs)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx (XXX)
xxxxx 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx typus x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas) 10 xxxxxxxxxx
xxxx. cum xxxxxx. tetanico xxxx xxxxx protein přibližně 25 mikrogramů
1 xxxxxxxxxxx xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Xx3+
2 xxxxxxxx xxxxxxxxxxxxx XXX technologií xx xxxxxxx xxxxxxxxxxxx xxxxx Xxxxxxxxxxxxx xxxxxxxxxx)
3 xxxxxxxxxxx na fosforečnan xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 pomnoženo xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx záškrtu, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx xx méně xxx 20 mezinárodních xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Xxxxxxxxxx pertussis
Pertussis xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 D xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Saukett) 32 D xxxxxxxx xxxxxxxx4
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X5 10 xxxxxxxxxx
Xxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxxxx X 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1 xxxxxxxxxxx xx hydratovaný xxxxxxxx xxxxxxx (0,6 xx Xx3+)
2 xxxx xxxxxx mez xxxxxxxxxxxxx (x = 0,95)
3 xxxxxxxxx na XXXX xxxxxxx
4 xxxx xxxxxxxxxxxx xxxxxxxx antigenu stanovené xxxxxxx xxxxxxxxxxxxxx xxxxxxx
5 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x kvasinkových xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx proti xxxxxxx, xxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx), hepatitidě X (rDNA), xxxxxx xxxxxxxx xxxxx (inaktivovaná) x xxxxxxxxxxx xxxxxxx xxxxx Xxxxxxxxxxx typu x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 ne méně xxx 20 IU
Tetani xxxxxxxxxx1 xx méně xxx 40 XX
Xxxxxxxx Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 20 xxxxxxxxxx
Xxxxxxxxxxx (PRN) 3 xxxxxxxxxx
Xxxxxxxx typi 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B2,3 10 xxxxxxxxxx
Xxxxx poliomyelitidis (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx5
Xxxxx 2 (MEF-1) 8 X xxxxxxxx antigenu5
Typus 3 (Saukett) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx typus x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx cum xxxxxxxxx meningococci xxxxx x2 50 mikrogramů
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 mg Xx3+)
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý xxxxxx (0,15 xx Xx3+)
3 vyrobeno rekombinantní XXX technologií x xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4 xxxxxxxxx xx Xxxx xxxxxxx
5 nebo xxxxxxxxxxxx množství xxxxxxxx xxxxxxxxx xxxxxxx imunochemickou xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární forma), xxxxxx (XXxX)
Xxxxx dávka (0,5 ml) xxxxxxxx xxxx xxxxxx látky:
Diphtheriae xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 mikrogramů
Pertussis xxxxxxxxxxxxxxx filamentosum* (XXX) 25 mikrogramů
Pertactinum* (69 xX) 8 xxxxxxxxxx
* xxxxxxxxxxx na xxxxxxxx xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx látka xxxxx xxxxxxx, xxxxxx x dávivému kašli (xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx (Tdap)
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum - Xxxxxxxxx 2 XX* (2 Lf)
Tetani anatoxinum - Minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx na fosforečnan xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx lékopisu.
NEBO
1bb) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx komponenta) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx než 20 xxxxxxxxxxxxx jednotek (XX) (5 Lf)
Bordetellae pertussis xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 miligramů Xx3+ x xxxxxxxxxxx xxxxxxx (AlPO4) 0,2 xxxxxxxxx Xx3+
1x) očkovací xxxxx proti xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:
Xxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) xxxxxxxx látka xxxxx tetanu:
Jedna dávka xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X v xxxxxx xxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis B - 10 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxx hepatitidě X x dospělé xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X - 20 xxxxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx dávka pro xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 pomnoženo xx xxxxxxxx diploidních buňkách (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx proti xxxxxxxxxx, příušnicím x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (kmen Enders’ Xxxxxxxxx) xx xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Lynn™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx rubeolae2 xxxxx xxxxxxxxxx (kmen Wistar XX 27/3) ne xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx dávka buněčné xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx embryí.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxx přenosné xxxxx x inaktivované xxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Xxxxxxx).....40 xxxxxxxxxxx X jednotek*
Virus poliomyelitis xxxxxxxxxxx xxxxx 2 (XXX-1) ..........8 xxxxxxxxxxx X jednotek*
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx)........32 xxxxxxxxxxx X xxxxxxxx*
* nebo xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx vhodné xxxxxxxxxxxxx xxxxxx.
1xx) xxxxxxxx látky xxxxx xxxxxxxxxxxxx infekcím xxxxxxxxx x sekvenčním xxxxxxxx:
1xxx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6B1 4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141 2,2 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19A1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx x xxxxxx xxxxxxxxx XXX197 x xxxxxxxxxx xx fosforečnan xxxxxxx (0,125 mg xxxxxxx).
1xxx) xxxxxxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7F, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33X.
1x) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - xx méně xxx 2 xxxxxxxxxxx jednotky (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 - xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)2 - 40 X jednotek xxxxxxxx
xxxxx 2 (kmen XXX-1)2 - 8 X jednotek xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)2 - 32 X xxxxxxxx xxxxxxxx
1 Adsorbováno xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum minimálně 2 XX* (2,5 Xx)
Xxxxxx xxxxxxxxxx xxxxxxxxx 20 IU* (5 Xx)
Xxxxxxxxx antigeny:
Pertussis xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 5 xxxxxxxxxx
Xxxxx poliomyelitidis (xxxxxxxxxxx)**
xxxxx 1 40 X xxxxxxxx xxxxxxxx
xxxxx 2 8 D xxxxxxxx xxxxxxxx
xxxxx 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xx fosforečnan xxxxxxx 1,5 mg (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (p = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx x Evropském xxxxxxxx.
** Xxxxxxxxxxx xx Xxxx buňkách.
1j) očkovací xxxxx xxxxx tuberkulóze (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx B xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx dávka (0,5 xx) vakcíny xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 xxxxxxxxxx
1 xxxxxxxxxx xx XX04X obsahující: - 3-0-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (MPL)2 50 mikrogramů
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (xxxxxx 0,5 miligramu Xx3+)
3 xxxxxxxx na xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx cerevisiae) xxxxxxxxxxxxx XXX technologií.
2. Antigenní xxxxxxx xxxxxxxxxx xxxxx xxx zvláštní xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B - 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Jedna dávka xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) očkovací xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka pro xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (RIT 4385) xxx. 103,7 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 pomnoženo xx xxxxxxx kuřecích embryí
2 xxxxxxxxx na xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx dávka xxxxxxx xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx a zarděnkám
Po xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxxx’ Edmonston) xx xxxx xxx 1x103 XXXX50*
Xxxxx parotitidis1 xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx X) xx méně xxx 12,5x103 CCID50*
Virus xxxxxxxx2 vivum attenuatum (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % infekční xxxxx buněčné xxxxxxx
1 xxxxxxxx xx buňkách xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx hepatitis X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx pro děti:
Virus xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx proti xxxxxxxxxx, příušnicím a xxxxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Schwarz) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (XXX 4385) xxx. 103,7 xxxxxxxx dávka xxx xxxxxxxx kulturu503
Rubeolae xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 infekční xxxxx xxx buněčnou kulturu503
1 xxxxxxxxx xx buňkách xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx diploidních xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám
Po rozpuštění xxxxxxxx xxxxx xxxxx (0,5 ml):
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (kmen Xxxxxx’ Xxxxxxxxx) xx xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, hladina B) xx méně xxx 12,5x103 XXXX503
Xxxxx xxxxxxxx2 xxxxx attenuatum (xxxx Xxxxxx XX 27/3) xx méně xxx 1x1103 XXXX503
* 50% xxxxxxxx dávka xxxxxxx xxxxxxx
1 xxxxxxxx na xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Xxxxx, XXx., XXX, XXXX, x. x.
Informace
Právní xxxxxxx x. 41/2023 Xx. xxxxx xxxxxxxxx xxxx 22.2.2023.
Xx xxx xxxxxxxx právní xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.